Eric Dobmeier, Director at Atara Biotherapeutics, Inc. (ATRA), bought 6,000 shares at $19.50 ($39K) on 2019-06-27, disclosed to the SEC on 2019-07-01.
Open-market purchase of $39k ATRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,000 | $0 | 0.0% |
| 2 | $19.50 | 2,000 | $39K | 100.0% |
| Total | $6.50 avg | 6,000 | $39K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |